In your experience what is the average size (no. of patients) that would be considered as "intermediate"? None of the regulations or guidances specify a number other than to indicate it is usually smaller than a study protocol.
------------------------------
Elizabeth Ashraf
Director Regulatory Intelligence
PTC Therapeutics
South Plainfield NJ
United States
------------------------------